Stocktoria
NP Life Sciences Health Industry Group Inc. ACAT
OTC · stock · Services-Educational Services
NP Life Sciences Health Industry Group Inc. financials (annual, from 10-K)
Bars are annual figures from 2019 to 2023; red bars are negative (a loss or cash outflow).
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $164,621 | $102,002 | $34,992 | $15,000 | $43,000 |
| Operating income | -$690 | -$18,855 | -$65,681 | -$131,091 | -$108,859 |
| Interest expense | $645 | $1 | — | — | — |
| Income tax | $1,600 | — | — | — | — |
| Net income | -$2,935 | -$18,856 | -$65,677 | -$131,065 | -$108,827 |
| EPS (diluted) | $0.00 | $0.00 | — | — | — |
| Operating cash flow | -$73,607 | $93,873 | -$90,625 | -$124,322 | -$4,266 |
| Cash & equivalents | $70,614 | $121,859 | $27,986 | $118,611 | $242,933 |
| Total assets | $76,864 | $127,784 | $38,411 | $118,611 | $250,097 |
| Total liabilities | $60,483 | $108,468 | $239 | $14,762 | $15,183 |
| Shareholders' equity | $16,381 | $19,316 | $38,172 | $103,849 | $234,914 |
Growth · year-over-year · Revenue CAGR 39.9%
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue growth | +61.4% | +191.5% | +133.3% | -65.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001781726 · US · as of 2023-12-31. facts plus Stocktoria's own computed scores — not investment advice.